Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help reduce disparities in the early diagnosis of breast cancer.

Reducing disparities in the early diagnosis of cancer, including breast cancer, is a specific priority within the National Health Service’s wider Core20Plus5 approach to reducing healthcare inequalities. Core20Plus25 targets the most deprived 20% of the population and other underserved groups, prioritising five clinical areas where faster improvement can most effectively reduce health inequalities. This is a key way that the National Health Service will work to end variation in early diagnosis of breast cancer and ensure that access to the best diagnosis is possible for everyone.

We are determined to close inequalities in screening and early diagnosis for ethnic minority communities and underserved communities through our new Neighbourhood Early Diagnosis Fund, which is part of £200 million for Cancer Alliances.

The NHS in England collects and analyses data to identify disparities, including in the early diagnosis of breast cancer. The National Disease Registration Service (NDRS) in NHS England is the cancer registry for England and collects data on the diagnosis and treatment of cancer patients. The data collected captures a patient’s complete journey from referral, diagnosis, treatment, outcomes, experience, and survival. NDRS’s strategic priorities focus on making data more timely and accessible, and better understanding health inequalities. To reduce unwarranted variation in outcomes for breast cancer patients, NHS England also funds National Clinical Audits, including for breast cancer. By analysing routine clinical data from NHS settings, these audits identify regional variations in care quality and establish best practices.